Delivery Order SPE2DB24D2003-SPE2DB25FXLP0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,688.89 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizure episodes in patients with epilepsy, representing a critical specialty...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a seizure rescue medication used for acute repetitive seizure clusters, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $4,107.10 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used to treat acute seizure clusters in epilepsy patients,...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of September 11, 2025. This firm fixed price, competitively awarded contract was not designated with a set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a seizure rescue medication indicated for acute repetitive seizure clusters, representing a specialized pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $9,124.26 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute seizure management, reflecting the Department of Defense's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $3,364.29 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on August 14, 2025, with completion scheduled for August 15, 2025. This competitively awarded, firm fixed-price contract was issued with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used in emergency seizure management, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a $1,801.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, with an ultimate completion date of June 5, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,726.02 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 25, 2025. This firm fixed-price contract, awarded on August 22, 2025, was not set-aside and represents a competitively awarded delivery order. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Valtoco is a critical emergency medication used primarily for acute seizure...
- The Defense Logistics Agency awarded a delivery order valued at $4,504.40 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizures, representing specialized...
- The Defense Logistics Agency awarded a $11,522.88 delivery order to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of May 2, 2025. This firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive basis with no set-aside designation. Performance will be...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLP0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 12, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded on August 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute repetitive seizure clusters in epilepsy patients, representing a specialized pharmaceutical commodity within the company's extensive medical supply portfolio. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company serves as a critical pharmaceutical distributor for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through this flexible contracting mechanism, demonstrating its established capability to meet federal procurement requirements across multiple therapeutic domains and customer bases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/11/25 |